Monday, September 29, 2014

Bacterial communication molecules can be manipulated to prevent cancer cells from spreading

›
Bacterial communication molecules can be manipulated to prevent cancer cells from spreading
Sunday, September 28, 2014

Rosuvastatin promotes bone growth in mice with achondroplasia symptoms

›
Skeletal dysplasia is a group of rare diseases that afflict skeletal growth through abnormalities in bone and cartilage. Its onset hits at...
Wednesday, September 24, 2014

FDA Approves Cerdelga (eliglustat) for Type 1 Gaucher Disease

›
The U.S. Food and Drug Administration today approved  Cerdelga  (eliglustat) for the long-term treatment of adult patients with the Type 1...
Tuesday, September 23, 2014

FDA Approves Arnuity Ellipta (fluticasone furoate) for the Treatment of Asthma

›
In continuation of my update on  Ellipta  (fluticasone furoate) GlaxoSmithKline plc  announced that the Food and Drug Administra...
Monday, September 22, 2014

FDA Approves Triumeq for the Treatment of HIV-1 Infection

›
ViiV Healthcare announced today that the U.S. Food and Drug Administration (FDA) has  approved  Triumeq (abacavir 600mg (below-Ist), dolut...
Friday, September 19, 2014

FDA Approves Movantik (naloxegol) for Opioid-Induced Constipation

›
In continuation with my update on  Movantik (naloxegol) The U.S. Food and Drug Administration today approved  Movantik (naloxegol), an...

Pfizer Announces Submission of Palbociclib New Drug Application to the FDA

›
Pfizer Inc. today announced it has completed the submission of a New Drug Application (NDA) to the United States Food and Drug Administrat...

FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure

›
Amgen announced the U.S. Food and Drug Administration (FDA) has granted priority review designation for ivabradine for the treatment of c...
Thursday, September 18, 2014

FDA Approves Eliquis (apixaban) for the Treatment of Deep Vein Thrombosis and Pulmonary Embolism

›
In continuation of my update on  Apixaban  (BMS-562247-01, tradename Eliquis) B ristol-Myers Squibb Company and Pfizer Inc.  announced the U...
Tuesday, September 16, 2014

Actavis Announces FDA Acceptance for Filing of NDA for Eluxadoline

›
Actavis plc (NYSE: ACT) today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing Actavis' New Drug App...

FDA Advisory Committee Votes 14-1 in Favor of Saxenda (liraglutide) for Obesity

›
In continuation of my update on  Lirglutide Novo Nordisk today announced that the Endocrinologic and Metabolic Drugs Advisory Committe...
Monday, September 15, 2014

New class of compounds protect brain cells from traumatic brain injury

›
A new class of compounds has now been shown to protect brain cells from the type of damage caused by blast-mediated traumatic brain injury...
Saturday, September 6, 2014

Prana's PBT2 receives FDA Orphan Drug designation for treatment of Huntington disease

›
Prana's PBT2 receives FDA Orphan Drug designation for treatment of Huntington disease
Thursday, September 4, 2014

Two Vaccines Help Cut Bacteria That Cause Meningitis, Study Finds

›
Two new vaccines can reduce the spread of meningitis by reducing the number of meningitis-causing bacteria that people carry, according to...
Wednesday, September 3, 2014

New Drug May Fight Serious Respiratory Virus in Infants

›
 An experimental drug shows promise in treating respiratory syncytial virus (RSV), a leading cause of pneumonia in infants, researchers re...